麻省理工学院在新加坡的研究公司成立新的研究小组,促进国家细胞疗法的研发

2019-07-15 06:52:00 来源:EEFOCUS
标签:
MIT's Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore’s National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies
 
S$10 million a year to be invested in SMART CAMP in a multi-year effort
 
New interdisciplinary research group, SMART CAMP, will bring together 35 MIT and Singapore investigators
 
Complementary and integrated programme with Singapore's Agency for Science Technology and Research (A*STAR) cell manufacturing effort, supported by the National Research Foundation (NRF)
 
SMART CAMP deploys MIT's innovation methodologies in Singapore's thriving biopharmaceutical industry, tapping market potential of billions a year
 
SINGAPORE - Media OutReach - 15 July 2019 - Cell therapies, where cellular material is injected, grafted or implanted into a patient to treat a range of illnesses and medical conditions, are a vital and integral component of medicine today - promising treatment of tissue degenerative diseases, cancer, and autoimmune disorders. 
 
However, significant challenges currently exist to prevent its widespread adoption including problems such as safety, potency, efficacy, and costs. To overcome these challenges, the Singapore-MIT Alliance for Research and Technology (SMART), together with A*STAR Institutes and supported by the National Research Foundation (NRF), has launched a new national initiative in Singapore that deploys MIT's globally renowned applied innovation methodology combined with Singapore's dynamic and growing biopharmaceutical manufacturing industry.
 
As part of the national initiative in cell manufacturing, CAMP is a new interdisciplinary research group within SMART that will focus on ways to produce living cells as medicine delivered to humans, leading to improved health outcomes. The National Research Foundation will support this multi-million, multi-year project that will bring together 35 MIT and Singapore investigators. They will be recruited from researchers working in SMART and Singapore institutes including A*STAR, KK Women's and Children's Hospital, the National University Hospital and local universities. Investigators from MIT in Cambridge, Massachusetts will also be recruited to support the programme.
 
"This is a field that is ripe for innovation, and one which we believe will benefit from both MIT's and Singapore's strengths," said Eugene Fitzgerald, CEO and Director of SMART. "By applying our problem-solving research methodology, coupled with Singapore's well-established biopharmaceutical manufacturing ecosystem, we are confident that we will be able to achieve market-ready breakthroughs."
 
Since its inception in Singapore in 2007, SMART has pioneered innovations that have transformed and are transforming fields such as autonomous driving, agriculture, microelectronics, mechanics and microfluidics platforms for biology and medical diagnostics, and antimicrobial resistance.
  
SMART CAMP will be helmed by Professor Krystyn Van Vliet of MIT and Professor Hanry Yu of NUS and A*STAR. Professor Van Vliet is an engineer with expertise at the interface of materials, mechanics, and biological systems and is an experienced leader, currently serving as the Associate Provost and the Director of Manufacturing Innovation at MIT. Her current research stemming from earlier SMART collaborations is in clinical trials at the Singapore General Hospital, and the prior SMART team that she led has spun off several MedTech companies in Singapore.     
 
Professor Van Vliet explained, "By addressing critical technology bottlenecks in how the next generation of personalised medicines is made, SMART CAMP researchers will help set the standards for innovating on quality by design. Imagine providing just the right living cells -- the most sophisticated drug factories we know -- to each patient, as quickly and safely as possible. Delivering on that promise requires exciting changes in the way we
understand, engineer, measure, and select cells that offer a safe and effective medicine for that person's ailment. And that goal, in turn, benefits from this investment in the research and researchers that can transform the manufacturing and analytics of biopharma products."     
 
Professor Yu is a physiologist with expertise interface between mechanobiology, biomaterials, imaging and AI-based data analytics. He is also a serial entrepreneur, recently forming six companies, and the founding member of the Mechanobiology Institute Research Centre of Excellence in Singapore.
 
"This programme integrates experts from various disciplines, training staff and students who can think through the translational pipelines from basic knowledge and technology into commercially viable and clinically relevant solutions", said Professor Yu.
 
"There is a global need for safe and cost-effective cell therapies," said Dr. Khiang Wee Lim, Executive Director of CREATE, NRF. "We believe that it is an area in which Singapore can provide innovation space and bring these transformational technologies to millions around the world. Advances in this area will also boost Singapore's biopharmaceutical industry, bringing innovations and helping gain a lead in this promising market that is estimated to be worth billions."
 
关注与非网微信 ( ee-focus )
限量版产业观察、行业动态、技术大餐每日推荐
享受快时代的精品慢阅读
 

 

继续阅读
麻省理工学院研究驾驶员对危险的探测速度,将用于改进现阶段的自动驾驶系统

想象一下,你正坐在一辆自动驾驶汽车的驾驶座上,汽车正沿着高速公路行驶,而你正低头看智能手机,突然,该车发现前方有一头麋鹿从树林里冲了出来,汽车提醒你要收回车辆控制权。然后,你从手机中抬头看路,那么,需要多长时间才能避免撞上麋鹿呢?

麻省理工斥资10亿美元成立新人工智能学院

北京时间10月16日早间消息,美国麻省理工学院周一宣布,该校计划成立一所新的人工智能学院,并计划投资10亿美元,其中三分之二的资金已经筹集完毕。

麻省理工用区块链技术给毕业生发证书

区块链技术能够让麻省理工学院(MIT)的毕业生以数字化的方式管理自己的学术履历。

中国工程院外籍院士身价暴增900亿美元,都是因为他
中国工程院外籍院士身价暴增900亿美元,都是因为他

11 月27 日,中国工程院选出85 名新院士,其中有18 名外籍院士。

晶圆生产总成本有望降低?这事又跟石墨烯有关
晶圆生产总成本有望降低?这事又跟石墨烯有关

2016年,全球半导体市场销售额达到历史最高点,达3390亿美元。 其中,半导体行业在全球范围内消费了大约72亿美元用作微电子元件基板的晶圆,晶圆可以转化为晶体管,发光二极管和其他电子和光子器件,是半导体行业的核心材料。

更多资讯
深耕本土 AI 医疗影像市场的背后思考
深耕本土 AI 医疗影像市场的背后思考

对AI医疗产品来说,2019年可以说是落地的关键一年。

飞利浦瞳乐光技术,呵护读写时光

全球照明领导者昕诺飞(阿姆斯特丹欧洲证券交易所代码:LIGHT)今日发布“黑科技”瞳乐光技术,赋能飞利浦轩系列LED台灯。随着当下国内近视趋势的不断低龄化,青少年的用眼健康早已成为了家长们重点关注的话题。

苹果健康团队大量员工离职,产品的发展情况不错为啥要走?

因为理念不同等原因,苹果健康团队近年来连连发生变动。

TE Connectivity连续两年跻身《财富》杂志 “改变世界的公司” 榜单

近日,全球连接和传感领域的领先企业TE Connectivity(以下简称“TE”)荣登《财富》杂志“2019改变世界的公司”榜单,并从全球52家获奖企业中脱颖而出,位列第四。这是TE连续第二年获此殊荣。 

植入芯片治肥胖,已经在小白鼠上成功试验

8月16日消息?近日,六名病态肥胖的美国人已同意参加斯坦福大学的一项脑芯片临床试验,当他们考虑食物时,这种脑芯片会产生微小的电击,以阻止他们产生吃东西的想法。